# Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)

> **NCT00108576** · PHASE3 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 101 (actual)

## Conditions studied

- PTSD

## Interventions

- **DRUG:** Divalproex
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00108576
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2005-08
- **Final completion:** 2005-09
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00108576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00108576, "Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00108576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*